Table 3. The relationship between IER3 expression and clinicopathological arguments of HCC based on the TCGA database.
Clinicopathologic arguments | Number | IER3 expression | R | p- value | |
---|---|---|---|---|---|
Age | ≥60 | 232 | 10.79 ± 0.91 | 0.006 | 0.938 |
<60 | 191 | 8.16 ± 0.94 | |||
Gender | Male | 280 | 9.53 ± 1.61 | 0.075 | 0.389 |
Female | 143 | 9.73 ± 1.61 | |||
Pathologic grade | G1–G2 | 265 | 9.47 ± 1.61 | 0.18 | 0.027 |
G3–G4 | 150 | 9.82 ± 1.60 | |||
Pathologic stage | I–II | 288 | 9.56 ± 1.61 | 0.677 | <0.001 |
III–IV | 103 | 9.66 ± 1.65 | |||
New tumour event after initial treatment | No | 196 | 9.49 ± 1.50 | 0.995 | <0.001 |
Yes | 198 | 9.65 ± 1.68 | |||
Alcohol history | No | 275 | 9.58 ± 1.67 | 0.265 | 0.003 |
Yes | 126 | 9.60 ± 1.59 |
Notes.
- HCC
- hepatocellular carcinoma
- IER3
- immediate early response 3
- TCGA
- The Cancer Genome Atlas
- R
- Pearson correlation coefficient